All News Sandoz Group AG

Equities

SDZ

CH1243598427

Market Closed - Swiss Exchange Other stock markets 11:30:20 2024-06-21 EDT			5-day change	1st Jan Change
32.78 ^CHF	-0.49%		+2.79%	+21.14%

06-14	Sandoz AG Re-Submits the Biosimilar Drug EG12014 (Trastuzumab Biosimilar) 150 Mg Powder BLA to the US FDA	CI
06-07	AbbVie's tight grip on Humira market raises concerns about biosimilars	RE

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sandoz AG Re-Submits the Biosimilar Drug EG12014 (Trastuzumab Biosimilar) 150 Mg Powder BLA to the US FDA	06-13	CI
Amgen Files BPCIA Complaint Against Celltrion Regarding Denosumab	06-10	AQ
European Biosimilar Regulatory Update	06-10	AQ
AbbVie's tight grip on Humira market raises concerns about biosimilars	06-07	RE
Improving access for patients: launch of Lisdexamfetamine further broadens Sandoz Canada portfolio	06-05	AQ
Fresenius Kabi Announces FDA Acceptance Of ABLA For Prolia® / Xgeva® (Denosumab) Biosimilar Candidate FKS518	05-31	AQ
Sandoz receives European Commission approval for Wyost and Jubbonti, the first and only biosimilars of denosumab in Europe	05-23	AQ
European Commission grants first-of-a-kind biosimilar approval	05-22	AQ
Sandoz: Marketing authorization for Wyost and Jubbonti in the EU	05-22	CF
Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars	05-22	MT
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe	05-22	GL
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	05-08	MT
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	05-08	MT
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	05-08	MT
Swiss Market Index Closes Higher; Sandoz Gains	05-08	MT
SANDOZ : Sandoz’s improvements are worth betting on	05-08
SANDOZ : Q1 miss not a worry; expect another boost for the share price	05-07
Sandoz: 5% sales growth in Q1	05-07	CF
Europe rises, buoyed by financial results	05-07	RE
Transcript : Sandoz Group AG, Q1 2024 Sales/ Trading Statement Call, May 07, 2024	05-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANDOZ : Sandoz’s improvements are worth betting on

May 08, 2024 at 08:08 am